by | Apr 28, 2023 | Publications
Pathogens. 2023 Mar 29;12(4):530. doi: 10.3390/pathogens12040530. ABSTRACT Severe cases of strongyloidiasis are most often associated with multiple causes of immune suppression, such as corticoid treatment and HTLV (human T-lymphotropic virus) coinfection. Diabetes is...
by | Apr 28, 2023 | Publications
Pathogens. 2023 Apr 13;12(4):592. doi: 10.3390/pathogens12040592. ABSTRACT Human T-cell leukemia virus-1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a slowly progressive neurological disease that arises from HTLV-1 infection....
by | Apr 28, 2023 | Publications
Viruses. 2023 Apr 14;15(4):963. doi: 10.3390/v15040963. ABSTRACT During the early 1980s, the first 3 human retroviruses were identified: human T-lymphotropic virus 1 and 2 (HTLV-1 and HTLV-2) and human immunodeficiency virus (HIV) […]. PMID:37112943 |...
by | Apr 28, 2023 | Publications
Front Immunol. 2023 Apr 11;14:1150285. doi: 10.3389/fimmu.2023.1150285. eCollection 2023. ABSTRACT INTRODUCTION: Fragmented genomic DNA is constitutively released from dying cells into interstitial fluid in healthy tissue. In cancer, this so-called...
by | Apr 28, 2023 | Publications
Ther Adv Infect Dis. 2023 Apr 20;10:20499361231165864. doi: 10.1177/20499361231165864. eCollection 2023 Jan-Dec. ABSTRACT Three Colombian patients with chronic HTLV-1 infection and severe intermediate and/or posterior uveitis are described. In one case, retinal...
by | Apr 27, 2023 | Publications
Trop Med Int Health. 2023 Apr 26. doi: 10.1111/tmi.13879. Online ahead of print. ABSTRACT OBJECTIVE: To determine the prevalence of signs and symptoms of HTLV-1 and 2 infection in paediatric patients. METHODS: We included cohort, case-control and descriptive...
